Arnoux V, Descotes J-L, Sengel C, Terrier N, Rambeaud J-J, Long J-A
Service d'urologie et transplantation rénale, CHU de Grenoble, BP 217, 38043 Grenoble cedex 09, France.
Prog Urol. 2013 Feb;23(2):99-104. doi: 10.1016/j.purol.2012.08.269. Epub 2012 Sep 26.
To compare morbidity, oncological and functional outcomes of percutaneous radiofrequency ablation (RFA) and partial nephrectomy in indications of renal tumor treatment with imperative nephron-sparing procedure.
Between January 2005 and December 2010, 50 consecutive patients were referred in our center for NP or RFA for a renal tumor with either a renal function impairment defined as estimated glomerular filtration (eGFR) less than 60 mL/min/1.73 m(2), and/or solitary kidney and/or bilateral tumors. Perioperative outcomes were compared.
Thirty-six PN and 14 RFA were performed. RFA patients were older (79.2 vs. 62.5 years old), had a higher ASA score (3 vs. 2), a lower RENAL score (6 vs. 7.5) and a lower rate of tumor on solitary kidney or bilateral tumors (P=0.009). Overall complications (29.4% vs. 6.3%), transfusions (20.6% vs. 0) and longer hospital stay (9 vs. 3 days) were more likely to occur in the NP group. During a median follow-up of 22 months (4.3-53.7), eGFR decrease was similar between the two groups (P=0.34). On multivariate analysis, PN was associated with an increased occurrence of overall complications (OR=14.09, P=0.02) but with a similar eGFR decrease. No patient died.
For patients with an indication of treatment of renal tumor and imperative nephron-sparing procedure, RFA seems to provide low morbidity and comparable functional outcomes as partial nephrectomy. Our limited follow-up does not permit to conclude on oncologic data.
在必须进行保肾手术的肾肿瘤治疗指征中,比较经皮射频消融(RFA)与部分肾切除术的发病率、肿瘤学及功能结局。
2005年1月至2010年12月期间,50例连续患者因肾功能损害(定义为估计肾小球滤过率(eGFR)低于60 mL/min/1.73 m²)和/或单肾和/或双侧肿瘤,被转诊至本中心接受部分肾切除术(PN)或RFA治疗肾肿瘤。比较围手术期结局。
进行了36例PN和14例RFA。RFA患者年龄较大(79.2岁对62.5岁),美国麻醉医师协会(ASA)评分较高(3对2),RENAL评分较低(6对7.5),单肾或双侧肿瘤的肿瘤发生率较低(P = 0.009)。PN组更易发生总体并发症(29.4%对6.3%)、输血(20.6%对0)及住院时间更长(9天对3天)。在中位随访22个月(4.3 - 53.7个月)期间,两组间eGFR下降相似(P = 0.34)。多因素分析显示,PN与总体并发症发生率增加相关(比值比[OR]=14.09,P = 0.02),但eGFR下降相似。无患者死亡。
对于有肾肿瘤治疗指征且必须进行保肾手术的患者,RFA似乎发病率较低,且功能结局与部分肾切除术相当。我们有限的随访无法得出肿瘤学数据的结论。